Asian Genomics Forum – Impact on Health and Beyond

AGT proudly co-organized the Asian Genomics Forum held on September 8, 2025 with Monash University Malaysia, supported by Bioeconomy Corporation, bringing together leading experts to explore how genetic insights are reshaping health, medicine, and society across Asia. The event drew researchers, healthcare professionals, and industry leaders eager to engage with cutting-edge findings and their real-world applications.

Forum Highlights

Professor Qasim Ayub

opened with a fascinating introduction to genetic variation and how hair shape (straight, wavy, or curly) has been a recurring feature of human evolution in Asia. His presentation showed that something as simple as hair tells us powerful stories about how our ancestors adapted to their environments.

The implications go far beyond hair. Professor Liu Jian Jun, co-founder of AGT, emphasized that much of genetic research has focused on European populations for decades, which means that many of the health insights, risk assessments, and even medical guidelines we rely on today are built on data that may not fully reflect Asian diversity. Asian-specific genetic testing helps to close this gap. By studying traits and conditions unique or more prevalent in Asian populations, researchers can uncover risk factors that would otherwise remain hidden and identify protective genetic variations that could lead to new medical discoveries. He also shared the latest findings beyond health conditions, including large-scale studies on height, educational attainment, and vitamin D, emphasizing that while genetic factors play a significant role, their influence should be acknowledged without overstating their impact in practical applications.

Professor Teh Lay Kek

shared how Malaysia is starting to bring genetics into everyday healthcare through a field called pharmacogenomics—the science of using your DNA to find the right medicine at the right dose. This is more than a scientific milestone; it's a practical tool that can transform how we approach treatment. Instead of relying on trial-and-error to see which drug works, doctors can now anticipate how a patient's body will respond, reducing the risk of side effects and ensuring that therapies are both safer and more effective.

For Asia, the promise of pharmacogenomics is especially important. Many of the world's most commonly prescribed drugs were developed and tested predominantly in Western populations, which means dosage guidelines or side-effect profiles may not always apply to Asian patients. By building genetic knowledge specific to Asian populations, Malaysia and the wider region can tailor treatments that truly reflect local needs. For example, variations in genes affecting drug metabolism can influence how patients respond to medicines for conditions like cancer, cardiovascular disease, or even common infections.

The Q&A session highlighted the audience's strong curiosity about how consumer genetic testing is evolving and where it is headed. Questions ranged from concerns about data accuracy, interpretation, and public understanding of DNA used for non-medical purposes, to how genetics might guide nutrition, eczema treatment, and even personalized learning for children. The panelists emphasized that while consumer tests can provide valuable insights, such as predicting tendencies for academic attainment or identifying sensitivities like gluten intolerance, significant challenges remain around regulatory frameworks, evidence interpretation, and public education. Importantly, they stressed that genetics should be viewed as one piece of the puzzle rather than a determinant of destiny, and that responsible use, clear standards, and meaningful translation into real-world applications will be key to the industry's future.

Food for Thought: Misconceptions About Genetic Testing

Beyond the Q&A, a recurring challenge in the field is public education. Many people still lump genetic testing together with non-scientific practices such as dermatoglyphics, personality quizzes like MBTI, or even fortune-telling. This blurring of lines between science and pseudoscience fuels confusion and, in some cases, skepticism toward legitimate genetic research.

Here is an important question for all of us: how do we as a society learn to distinguish between what is scientifically validated and what only appears scientific on the surface? The challenge is made more difficult by the way some companies market consumer genetic tests with exaggerated promises or simplified claims that overlook scientific nuance. This can further mislead the public and undermine trust.

As genetic testing becomes more widely available, clear communication and ongoing education will be critical, both to help people understand what DNA testing can and cannot do and to ensure these tools are applied responsibly. At AGT, we see it as part of our mission to bridge this gap by helping the public better understand both the true nature and the scientific basis of genetic testing.

This commitment connects directly to the message of the forum. It reminded us that genetics is not only about science in a lab but also about our health, our families, and our future. By focusing on Asian populations, researchers are ensuring that discoveries benefit people here at home rather than being limited to insights drawn mainly from the western world.

Looking Ahead

At AGT, we believe in making genetic knowledge both accessible and meaningful for everyone. The insights shared at the Asian Genomics Forum are only the beginning, and we look forward to more collaborations, more research, and more opportunities to help families and communities understand how genetics can improve health and well-being.

Stay tuned for updates on future forums, workshops, and community programs. Together, we can turn genetic knowledge into brighter futures.

Explore our DNA tests: Decode Talent · Decode Health · Decode Nutrition. Related event: A Breakthrough in Genetic Testing: AGT Crosses Borders at Malaysia–Indonesia Bio Partnering 2025.